Proof-of-Concept, Double-Blind, Placebo-Controlled Study for CX-8998, a State-Dependent T-Type Calcium (TTCC) Modulator in Essential Tremor Patients (T-CALM): Efficacy and Safety Results

被引：0
|
作者：
Papapetropoulos, Spyros [1 ]
Boyer, Stacey [1 ]
Lee, Margaret S. [1 ]
机构：
[1] Cavion Inc, Charlottesville, VA USA
来源：
NEUROTHERAPEUTICS | 2019年 / 16卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：917 / 917
页数：1
相关论文
共 50 条
  • [1] Efficacy Result from a Phase 2, Double-Blind, Placebo-Controlled Study of CX-8998 a State-Dependent T-Type Calcium (Cav3) Channel Modulator in Essential Tremor Patients (T-CALM)
    Papapetropoulos, Spyros
    Lee, Margaret
    Boyer, Stacey
    Krouse, Andrew
    Pahwa, Rajesh
    Lyons, Kelly
    Ondo, William
    Jinnah, H.
    Elble, Rodger
    [J]. NEUROLOGY, 2019, 92 (15)
  • [2] Efficacy and Safety of the T-Type Calcium Channel Modulator CX-8998 in T-CALM, a Randomized, Double-Blind, Placebo-Controlled, Phase 2a Trial in Participants with Essential Tremor
    Ondo, William
    Papapetropoulos, Spyros
    Lee, Margaret S.
    Versavel, Stacey
    Krouse, Andrew
    Newbold, Evan
    Jinnah, Hyder A.
    Pahwa, Rajesh
    Lyons, Kelly E.
    Zesiewicz, Theresa
    Hedera, Peter
    Handforth, Adrian
    Elder, Jenna
    Versavel, Mark
    Elble, Rodger
    [J]. ANNALS OF NEUROLOGY, 2020, 88 : S175 - S175
  • [3] Efficacy and safety of CX-8998 in T-CALM, a randomized, double-blind, placebo-controlled, phase 2a trial in participants with essential tremor: subgroup analysis by baseline tremor severity
    Jinnah, H.
    Papapetropoulos, S.
    Lee, M.
    Versavel, S.
    Newbold, E.
    Pahwa, R.
    Lyons, K.
    Elble, R.
    Ondo, W.
    Zesiewicz, T.
    Hedera, P.
    Handforth, A.
    Elder, J.
    Versavel, M.
    [J]. MOVEMENT DISORDERS, 2020, 35 : S687 - S687
  • [4] Efficacy and Safety of CX-8998 in T-CALM, a Randomized, Double-Blind, Placebo-Controlled, Phase 2a Trial in Participants With Essential Tremor: Subgroup Analysis by Baseline Tremor Severity
    Jinnah, Hyder A.
    Papapetropoulos, Spyros
    Lee, Margaret
    Boyer, Stacey
    Newbold, Evan
    Pahwa, Rajesh
    Lyons, Kelly E.
    Elble, Rodger
    Ondo, William
    Zesiewicz, Theresa
    Hedera, Peter
    Handforth, Adrian
    Elder, Jenna
    Versavel, Mark
    [J]. NEUROLOGY, 2020, 94 (15)
  • [5] A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial of CX-8998, a Selective Modulator of the T-Type Calcium Channel in Inadequately Treated Moderate to Severe Essential Tremor: T-CALM Study Design and Methodology for Efficacy Endpoint and Digital Biomarker Selection
    Papapetropoulos, Spyros
    Lee, Margaret S.
    Boyer, Stacey
    Newbold, Evan J.
    [J]. FRONTIERS IN NEUROLOGY, 2019, 10
  • [6] Efficacy and safety of a T-type calcium channel blocker in patients with neuropathic pain: A proof-of-concept, randomized, double-blind and controlled trial
    Kerckhove, N.
    Pereira, B.
    Soriot-Thomas, S.
    Alchaar, H.
    Deleens, R.
    Hieng, V. S.
    Serra, E.
    Lanteri-Minet, M.
    Arcagni, P.
    Picard, P.
    Lefebvre-Kuntz, D.
    Maindet, C.
    Mick, G.
    Balp, L.
    Lucas, C.
    Creach, C.
    Letellier, M.
    Martinez, V.
    Navez, M.
    Delbrouck, D.
    Kuhn, E.
    Piquet, E.
    Bozzolo, E.
    Brosse, C.
    Lietar, B.
    Marcaillou, F.
    Hamdani, A.
    Leroux-Bromberg, N.
    Perier, Y.
    Vergne-Salle, P.
    Gov, C.
    Delage, N.
    Gillet, D.
    Romettino, S.
    Richard, D.
    Mallet, C.
    Bernard, L.
    Lambert, C.
    Dubray, C.
    Duale, C.
    Eschalier, A.
    [J]. EUROPEAN JOURNAL OF PAIN, 2018, 22 (07) : 1321 - 1330
  • [7] Safety and efficacy of erenumab in patients with trigeminal neuralgia in Denmark: a double-blind, randomised, placebo-controlled, proof-of-concept study
    Andersen, Anne Sofie Schott
    Maarbjerg, Stine
    Noory, Navid
    Heinskou, Tone Bruvik
    Forman, Julie Lyng
    Cruccu, Giorgio
    Ashina, Messoud
    Bendtsen, Lars
    [J]. LANCET NEUROLOGY, 2022, 21 (11): : 994 - 1003
  • [8] Efficacy and Safety of ASP0819 in Patients with Fibromyalgia: Results of a Proof-of-Concept, Randomized, Double-Blind, Placebo-Controlled Trial
    Arnold, Leslie M.
    Blauwet, Mary Beth
    Tracy, Katherine
    Cai, Na
    Walzer, Mark
    Blahunka, Paul
    Marek, Gerard J.
    [J]. JOURNAL OF PAIN RESEARCH, 2020, 13 : 3355 - 3369
  • [9] A Phase 2 Efficacy Study of an Oral, Potent and Selective T-Type Calcium (Cav3) Modulator in Essential Tremor Patients (T-CALM): Design and Dose Selection Rationale
    Papapetropoulos, Spiridon
    Maricich, Yuri
    Lee, Margaret
    Boyer, Stacey
    Silver, Bruce
    [J]. NEUROLOGY, 2018, 90
  • [10] Proof-of-Principle Quantitative EEG Study of CX-8998, an Oral, Potent and Selective T-Type Calcium antagonist in development for symptomatic treatment of Essential Tremor and Parkinson's disease Tremor
    Papapetropoulos, S.
    Lee, M.
    Boyer, S.
    [J]. MOVEMENT DISORDERS, 2018, 33 : S22 - S22
12345